Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00002434 · ClinicalTrials.gov registry record · NA
A Study of Neutrexin Plus Leucovorin in the Treatment of Pneumocystis Carinii Pneumonia (PCP)
A NA study, sponsored by U.S. Bioscience.
- Completed
- Registry status
- NA
- Development phase
NCT00002434 is a NA study that has completed, run by U.S. Bioscience.
The verdict
NCT00002434, a NA study, has completed, sponsored by U.S. Bioscience.
- COMPLETED
- Registry status
- NA
- Development phase
Study Summary
To evaluate the safety and efficacy of trimetrexate glucuronate with leucovorin protection in patients with Pneumocystis carinii pneumonia (PCP) who are refractory to or have demonstrated severe or life-threatening toxicities to standard therapies (e.g., TMP/SMX or parenteral pentamidine).
Interventions
- DRUG Leucovorin calcium
- DRUG Trimetrexate glucuronate
Trial Details
| Field | Value |
|---|---|
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00002434
The ClinicalTrials.gov registry entry for NCT00002434 describes a study currently listed as completed, categorized as NA. An enrollment target was not published in the registry record, which is common for early-stage or observational entries. The listed sponsor is U.S. Bioscience, which has 5 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Leucovorin calcium is the first listed.
NCT00002434 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00002434 about?
NCT00002434 is a clinical study titled "A Study of Neutrexin Plus Leucovorin in the Treatment of Pneumocystis Carinii Pneumonia (PCP)". To evaluate the safety and efficacy of trimetrexate glucuronate with leucovorin protection in patients with Pneumocystis carinii pneumonia (PCP) who are refractory to or have demonstrated severe or life-threatening toxicities to standard therapies (e.g., TMP/SMX or parenteral pentamidine).
What is the current status of trial NCT00002434?
This trial is currently completed. It is a NA study.
What interventions are being tested in trial NCT00002434?
The interventions under investigation include: Leucovorin calcium (DRUG), Trimetrexate glucuronate (DRUG).
Who is sponsoring clinical trial NCT00002434?
This trial is sponsored by U.S. Bioscience, which has 5 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.